Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dormer, R L
Right arrow Articles by McPherson, M A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dormer, R L
Right arrow Articles by McPherson, M A
Topic Collections
Right arrowRelated Article
Thorax 2005;60:55-59
© 2005 BMJ Publishing Group Ltd & British Thoracic Society


CYSTIC FIBROSIS

Sildenafil (Viagra) corrects {Delta}F508-CFTR location in nasal epithelial cells from patients with cystic fibrosis

R L Dormer1, C M Harris1, Z Clark1, M M C Pereira1, I J M Doull2, C Norez3, F Becq3, M A McPherson1

1 Department of Medical Biochemistry and Immunology, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XN, UK
2 Department of Child Health, University Hospital of Wales, Heath Park, Cardiff CF14 4XN, UK
3 Institut de Physiologie et Biologie Cellulaires, UMR 6187, CNRS, Université de Poitiers, France

Correspondence to:
Correspondence to:
Dr R L Dormer
Department of Medical Biochemistry and Immunology, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XN, UK; dormer{at}cardiff.ac.uk

Background: Most patients with cystic fibrosis (CF) have a {Delta}F508 mutation resulting in abnormal retention of mutant gene protein ({Delta}F508-CFTR) within the cell. This study was undertaken to investigate {Delta}F508-CFTR trafficking in native cells from patients with CF with the aim of discovering pharmacological agents that can move {Delta}F508-CFTR to its correct location in the apical cell membrane.

Method: Nasal epithelial cells were obtained by brushing from individuals with CF. CFTR location was determined using immunofluorescence and confocal imaging in untreated cells and cells treated with sildenafil. The effect of sildenafil treatment on CFTR chloride transport function was measured in CF15 cells using an iodide efflux assay.

Results: In most untreated CF cells {Delta}F508-CFTR was mislocalised within the cell at a site close to the nucleus. Exposure of cells to sildenafil (2 hours at 37°C) resulted in recruitment of {Delta}F508-CFTR to the apical membrane and the appearance of chloride transport activity. Sildenafil also increased {Delta}F508-CFTR trafficking in cells from individuals with CF with a single copy {Delta}F508 ({Delta}F508/4016ins) or with a newly described CF trafficking mutation (R1283M).

Conclusions: The findings provide proof of principle for sildenafil as a {Delta}F508-CFTR trafficking drug and give encouragement for future testing of sildenafil and related PDE5 inhibitors in patients with CF.


Keywords: cystic fibrosis; sildenafil (Viagra); genetics


Related Article

Airwaves
Wisia Wedzicha
Thorax 2005 60: 1a. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
L. L. Clarke
Phosphodiesterase 5 Inhibitors and Cystic Fibrosis: Correcting Chloride Channel Dysfunction
Am. J. Respir. Crit. Care Med., March 1, 2008; 177(5): 469 - 470.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
B. Lubamba, H. Lecourt, J. Lebacq, P. Lebecque, H. De Jonge, P. Wallemacq, and T. Leal
Preclinical Evidence that Sildenafil and Vardenafil Activate Chloride Transport in Cystic Fibrosis
Am. J. Respir. Crit. Care Med., March 1, 2008; 177(5): 506 - 515.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Robert, G. W. Carlile, C. Pavel, N. Liu, S. M. Anjos, J. Liao, Y. Luo, D. Zhang, D. Y. Thomas, and J. W. Hanrahan
Structural Analog of Sildenafil Identified as a Novel Corrector of the F508del-CFTR Trafficking Defect
Mol. Pharmacol., February 1, 2008; 73(2): 478 - 489.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. F. Poschet, G. S. Timmins, J. L. Taylor-Cousar, W. Ornatowski, J. Fazio, E. Perkett, K. R. Wilson, H. D. Yu, H. R. de Jonge, and V. Deretic
Pharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis
Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L712 - L719.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
Poster presentations
Thorax, December 1, 2006; 61(suppl_2): ii57 - ii133.
[Full Text] [PDF]


Home page
ThoraxHome page
A Moeller, F Horak Jr, C Lane, D Knight, A Kicic, S Brennan, P Franklin, J Terpolilli, J H Wildhaber, and S M Stick
Inducible NO synthase expression is low in airway epithelium from young children with cystic fibrosis
Thorax, June 1, 2006; 61(6): 514 - 520.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
D S Urquhart, H Montgomery, and A Jaffe
Assessment of hypoxia in children with cystic fibrosis
Arch. Dis. Child., November 1, 2005; 90(11): 1138 - 1143.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 BMJ Publishing Group Ltd & British Thoracic Society